Post-traumatic stress disorder (PTSD) affects millions of people worldwide. Many people try therapy, medication, or both, yet still struggle with symptoms. These may include ongoing nightmares, sudden and distressing memories, or a constant feeling of being on edge that doesn’t seem to fade.

This experience is more common than many realize. Research shows that while standard PTSD treatments help a lot of people, many continue to have significant symptoms even after completing care.

When early treatments don’t bring enough relief, it doesn’t mean you’ve run out of options. New advances in trauma science are leading to treatments that target the brain and nervous system. This offers additional paths forward beyond traditional talk therapy.

Table of Contents

What Are the Gold Standard Treatments for PTSD?

Before discussing alternatives, you need to understand what “standard therapy” actually means.

The 2023 VA/DoD Clinical Practice Guideline recommends three specific first-line trauma-focused psychotherapies. These include Cognitive Processing Therapy (CPT), Eye Movement Desensitization and Reprocessing (EMDR), and Prolonged Exposure (PE). These approaches work by helping you process traumatic memories differently.

These evidence-based treatments are typically delivered over 8–15 sessions, depending on the protocol and setting. CPT is often 12 sessions, while PE and EMDR may vary in the number of sessions.

  • Cognitive Processing Therapy (CPT) focuses on challenging and changing negative beliefs about the traumatic event. You examine how it has affected your thoughts about safety, trust, and control. This cognitive therapy approach helps you identify and restructure unhelpful thought patterns.
  • Prolonged Exposure (PE) involves gradually confronting trauma-related memories, feelings, and situations you’ve been avoiding. Through repeated exposure sessions, your brain learns that these memories, while painful, aren’t dangerous. This helps reduce the emotional pain associated with these experiences.
  • Eye Movement Desensitization and Reprocessing (EMDR) combines exposure to distressing memories with bilateral stimulation (typically eye movements). This approach helps survivors process what happened in a new way. Recent 2024 research from Wright and colleagues confirms EMDR is equally effective as other top-tier therapies.

According to the National Center for PTSD, about 53% of 100 patients who receive one of these three therapies will no longer have PTSD. For many people, these interventions provide significant relief.

But what about when they don’t?

What to Do When PTSD Therapy Doesn’t Work

You’ve completed therapy sessions. You’ve done the homework. But you’re still struggling.

This situation is called treatment-resistant PTSD. It refers to post-traumatic stress disorder that persists after evidence-based interventions have been administered over a prolonged period.

Several factors might explain why standard approaches aren’t providing adequate relief:

  • Complex or repeated traumatic events can make recovery more challenging. If you experienced childhood trauma followed by adult incidents, standard protocols may need adjustment. Complex PTSD often requires specialized care approaches.
  • Co-occurring mental health conditions significantly affect outcomes. Research shows 80% of people with PTSD also have another condition. These often include depression, generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, bipolar disorder, or substance use disorders. These comorbidities can complicate recovery and may need simultaneous care.
  • Physical health problems matter more than you might think. Chronic pain, sleep disorders, or injuries from the original incident can limit how you engage with therapy and may worsen mental health symptoms.
  • Dissociation during sessions can prevent healing. Dissociative symptoms, or feeling disconnected from your emotions or body during exposure work, mean the therapy won’t have its intended effect. Some survivors experience this as a protective mechanism.

When standard approaches fall short, emerging interventions offer new pathways to healing.

Emerging and New Treatments for PTSD: Stellate Ganglion Block (SGB)

When standard therapy and medication do not provide enough relief, some individuals explore newer, medically supervised options designed to work more directly with the brain and nervous system.

Two of the most discussed approaches are stellate ganglion block (SGB) and ketamine-based therapies. These treatments are not first-line care, but they are being studied for people with treatment-resistant PTSD.

1. Stellate Ganglion Block (SGB)

A stellate ganglion block is a brief medical procedure in which a physician injects a local anesthetic near a group of nerves at the base of the neck. These nerves are connected to the body’s “fight-or-flight” system, which is often overactive in PTSD. The procedure itself takes only minutes, though patients are monitored afterward for safety.

Researchers believe SGB may reduce PTSD symptoms by calming this overactive stress response. This includes signals involving the amygdala, a brain region tied to fear and threat detection. A 2020 randomized controlled trial found that SGB led to greater symptom reduction than a sham procedure in a military population.

However, the U.S. Department of Veterans Affairs and the Department of Defense concluded in their 2023 Clinical Practice Guideline that the evidence remains insufficient to recommend for or against SGB. Some individuals report symptom relief lasting weeks to months, but responses vary, and long-term effectiveness remains uncertain. Temporary side effects, such as drooping eyelid, nasal congestion, or hoarseness, usually resolve within hours.

2. Ketamine and Esketamine Therapy

Ketamine, originally developed as an anesthetic, has gained attention for its rapid effects on severe mental health symptoms. In PTSD care, it is typically used in two forms.

IV ketamine is administered through an intravenous infusion over 40–60 minutes in a medical setting, while Spravato (esketamine) is an FDA-approved nasal spray used under supervision. Esketamine is approved for treatment-resistant depression and is sometimes used off-label for PTSD.

Ketamine works differently from traditional antidepressants. It affects glutamate, a key brain chemical involved in learning and stress responses, and may help the brain form new, healthier neural connections. Clinical studies show that some people experience symptom relief within 24 hours. This makes it a potential option for individuals who have not responded to other treatments.

Because ketamine can cause sedation, dissociation, blood pressure changes, and carries misuse risk, treatment must occur in certified medical settings under strict monitoring. FDA requires esketamine to be administered through a Risk Evaluation and Mitigation Strategy (REMS) program to ensure patient safety.

3. Brain Stimulation and Other Approaches

When medications and talk therapy haven’t provided adequate relief, targeting the brain directly through non-invasive stimulation represents another potential avenue.

Transcranial Magnetic Stimulation (TMS)

TMS sends magnetic pulses to specific brain regions involved in mood regulation and stress response. The pulses are painless and don’t require anesthesia.

TMS is well-established for treatment-resistant depression. For PTSD, systematic reviews report mixed results, and the strength of evidence varies by protocol and study quality. The 2023 VA/DoD guideline found insufficient evidence to recommend for or against TMS for PTSD (Recommendation 25).

This doesn’t mean TMS never benefits PTSD patients. Some individuals do report improvements, particularly when TMS is combined with psychotherapy. However, it’s important to have realistic expectations based on current evidence.

Virtual Reality Exposure Therapy

Virtual reality exposure therapy combines traditional exposure therapy with technology. You use computer-generated simulations to confront trauma-related situations in a controlled environment gradually.

This may be particularly helpful for veterans with combat-related experiences or others who experienced traumatic events in specific environments. The technology allows repeated practice without visiting actual locations.

Early research shows promise for this innovative approach, though more randomized controlled trials are needed to establish it as a standard option.

Other Therapeutic Approaches

  • Written Exposure Therapy offers a briefer alternative to traditional prolonged exposure. Instead of verbally recounting experiences, you write about them in structured sessions. Research shows this approach may be just as effective as lengthier first-line options for some individuals, with potentially lower treatment dropout rates.
  • Group therapy sessions allow trauma survivors to connect with others who understand their experiences, reducing isolation and shame. Group formats work best as supplements to individual therapy rather than replacements.
  • Creative therapies like art therapy or music therapy can help some individuals access and process traumatic memories in non-verbal ways. While not considered first-line approaches, these can be valuable adjuncts.

PTSD Treatments That Work When Therapy Fails: Medication Options

While cutting-edge procedures get attention, traditional medications remain an important option, especially when combined with therapy.

FDA-Approved Medications

Only two medications have FDA approval specifically for treating PTSD: paroxetine and sertraline. Both are selective serotonin reuptake inhibitors (SSRIs) that help regulate brain chemistry and reduce symptoms.

Research shows that fluoxetine, venlafaxine (an SNRI), and paroxetine provide benefit when used as the sole medication. SSRIs and SNRIs generally offer a well-tolerated side-effect profile compared to older medications.

These work best when prescribed by a mental health professional who understands trauma. Your psychiatrist or primary care physician can monitor your response and adjust as needed.

Medications for Specific Symptoms

The 2023 VA/DoD guideline suggests prazosin for PTSD-related nightmares (weak recommendation). Prazosin blocks certain adrenaline receptors, reducing the intensity of nightmares and disturbed awakenings.

Sleep disturbance is one of the most common and distressing PTSD symptoms. Addressing sleep first can sometimes improve your ability to engage in trauma-focused therapy and enhance overall outcomes.

When Standard Medications Don’t Work

If you haven’t responded to the standard options, augmentation strategies are available. Aripiprazole augmentation involves adding a low dose of an antipsychotic medication to your antidepressant. This can be particularly helpful if you have severe hyperarousal, severe anxiety, or co-occurring depression.

Some expert algorithms propose targeting nightmares and sleep first. And then addressing daytime symptoms, though specific recommendations vary by clinical context.

Working With Your Mental Health Professional

Medication management for chronic PTSD requires patience. Traditional medications may take 4-6 weeks to show full benefits. Your provider will monitor for symptom reduction, improvements in daily functioning, side effects that may need adjustment, and the need for dosage changes or augmentation.

Don’t stop medications abruptly, even if you feel better. Work with your provider to develop a comprehensive plan.

When Should I Seek These Advanced Treatments?

Consider advanced options if:

  • You’ve completed at least 12–16 therapy sessions without adequate improvement
  • You’ve tried at least two different medications at adequate doses for sufficient time periods
  • Your symptoms significantly interfere with daily functioning, relationships, or work
  • Co-occurring conditions are complicating your recovery

If you’re experiencing thoughts of self-harm or suicide, seek immediate help. Contact the 988 Suicide & Crisis Lifeline by calling or texting 988, or contact your local emergency services.

However, these advanced options work best as part of comprehensive care, not as replacements for all other interventions. Continue working with a mental health professional who can coordinate your overall care plan.

Understanding Your PTSD Diagnosis

Before pursuing advanced approaches, ensure you have a proper diagnosis. According to the Diagnostic and Statistical Manual (DSM-5-TR), a PTSD diagnosis requires exposure to actual or threatened death, serious injury, or sexual assault, plus intrusion symptoms, avoidance behaviors, negative changes in thoughts and mood, and changes in arousal and reactivity.

Some people may have acute stress disorder, which has similar symptoms but occurs within the first month after a traumatic event. Acute stress disorder may resolve on its own or develop into chronic PTSD.

Find Your Path to Recovery at Serenity Mental Health Centers

At Serenity Mental Health Centers, we understand that PTSD doesn’t respond to one-size-fits-all solutions. Since 2017, we’ve specialized in evidence-based interventions for treatment-resistant PTSD. Our experienced psychiatrists combine proven therapies with advanced options like ketamine therapy, TMS, and comprehensive medication management.

When you choose Serenity, you’ll work with a dedicated psychiatrist who takes the time to understand your unique history, symptoms, and goals. We believe in personalized care that addresses your whole experience. With locations across the United States, expert care is accessible.

Important to note: Not all treatments are appropriate for every patient. Some uses discussed in this article are off-label and require individualized medical judgment. No treatment guarantees specific outcomes.

Ready to explore options that could bring relief? Schedule a consultation with a Serenity psychiatrist today and take the first step toward recovery.